T1D Flashcards
what is T1D
absolute insulin deficiency due to destruction of beta-cells that produce insulin in pancreatic islet of Langerhans
little or no endogenous insulin secretory capacity
most commonly occurs
before adulthood
microvascular complications include
- retinopathy
- neuropathy
- nephropathy
macrovascular complications include
- premature CVD
- peripheral arterial disease
- MI, stroke
macrovascular complications are to do with the
heart
metabolic complications
DKA
hypoglycaemia
Typical features in adult pt presenting with T1D
Hyperglycaemia
Random BG conc >11mmol/L
Ketosis
Rapid weight loss
BMI <25kg/m2
Under 50
Personal/FHx autoimmune disease
target HbA1c for T1D
48mmol/mol (6.5%) or lower
In adults, T1D should be diagnosed on clinical ground if pt presents with hyperglycaemia and one or more of the following features (may not always be present):
Ketosis
Rapid weight loss
Age of onset <50 (but do not rule out if 50 or older)
BMI <25 (but do not rule out if 25 or more)
P/FHx autoimmune disease
What are the figures of BG conc patients should aim for at different times of the day?
Fasting BG of 5-7 on waking
4-7 before meals at other times of day
5-9 at least 90 mins after eating
At least 5 when driving as per DVLA
In a child, T1D suspected if they present with hyperglycaemia and characteristic features of
Polyuria
Polydipsia
Weight loss
Excessive tiredness
what type of monitoring to offer pt
Continuous glucose monitoring (CGM) should be offered to support pt to self-manage their diabetes
Pt using CGM will still need to take capillary BG measurements, but can do this less often
Pt unwilling to or unable to use CGM should be offered capillary BG monitoring and be advised to measure their BG conc at least 4x/day, including before each meal and before bed
when to consider metformin (unlicensed) as an addition to insulin
BMI 25 or more (23 or more for SA ethnicity) and wishing to improve BG control while minimising effective insulin dose
This is because pt who are overweight can develop insulin resistance!
all patients will require therapy with
insulin
Multiple daily injection basal-bolus insulin regimens
One or more separate daily injections of intermediate-acting insulin or long-acting insulin analogue as the basal insulin
ALONGSIDE multiple bolus injections of short acting insulin before meals
Allows flexibility to tailor insulin therapy with the carbohydrate load of each meal
Mixed (biphasic) regimen
1,2 or 3 insulin injections per day of SA insulin mixed with intermediate acting insulin
May be mixed by pt at time of injection, or a premixed product may be used
Continuous SC insulin infusion (insulin pump)
Regular or continuous amount of insulin (usually rapid acting insulin analogue or soluble insulin) delivered by a programmed pump and insulin storage reservoir via SC needle or cannula
what is the recommended 1st line insulin regimen
multiple daily injection basal-bolus insulin regimens
give examples of 1st line basal insulin regimens
- BD insulin detemir (Levemir) as long acting basal
- OD insulin glargine (toujeo, Lantus) if above not tolerated or BD regimen not accepted
- OD degludec (tresiba) If particular concern about nocturnal hypo
- alternative for pt who need help with injection admin from carer or HCP: OD ultra long acting - degludec or glargine (tresiba, toujeo)
are non-basal-bolus insulin regimens recommended for adults with newly diagnosed T1D
no
….. insulin analogue is recommended as the mealtime insulin replacement, rather than soluble human insulin or animal insulin
rapid acing
when to inject rapid acting insulin
- inject before meals
- routine use after meals should be discourages
if a multiple daily injection basal-bolus regimen is not possible, consider ……. regimen if preferred
BD biphasic insulin regimen
In pt using BD human mixed insulin regimen and have hypoglycaemia that affects their QoL, trial a
BD anagolue mixed insulin regimen
Continuous SC insulin infusion (insulin pump) therapy should only be offered to pt who
- suffer disabling hypoglycaemia while attempting to achieve their HbA1c level
- or who have had high HbA1c levels (69 mmol/mol (8.5%) or above) with multiple daily injection therapy (including the use of LA insulin analogues if appropriate) despite high level of care
factors that can increase the required insulin dose
Infection, stress, accidental or surgical trauma
factors that can decrease insulin requirements, therefore increase susceptibility to hypo episodes
physical activity, intercurrent illness, reduced food intake, impaired renal function, some endocrine disorders (e.g. thyroid, addisons disease, coeliac)
assess pt awareness of hypo annually using .. (2)
Gold score or the Clarke score
what can reduce warning signs of hypo
Increase in the frequency of hypoglycaemic episodes
Impaired awareness of symptoms below the following BGC….. is associated with a significantly increased risk of severe hypoglycaemia
3mmol/litre
this class of drugs can blunt hypo awareness by reducing warning signs e.g. tremor
beta blockers
can patients experience loss of awareness of hypo after transfer from animal to human insulin
conflicting evidence
Clinical studies do not confirm that human insulin decreases hypo awareness